MGP
RPRX icon

M&G plc’s Royalty Pharma RPRX Stock Holding History

M&G plc’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,200
Closed -$619K – 446
2025
Q2 		$619K Hold
17,200
– – ﹤0.01% 362
2025
Q1 		$533K Hold
17,200
– – ﹤0.01% 380
2024
Q4 		$447K Hold
17,200
– – ﹤0.01% 389
2024
Q3 		$482K Hold
17,200
– – ﹤0.01% 388
2024
Q2 		$447K Buy
+17,200
New +$477K ﹤0.01% 377

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

M&G plc's RPRX Position: Q3 2025 in Review

M&G plc sold out of Royalty Pharma (RPRX) in Q3 2025, closing a stake of 17,200 shares — an estimated $619K sold.

M&G plc first reported a position in RPRX in Q2 2024 and held it in 5 quarters. The position peaked at $619K in Q2 2025. 487 funds tracked by Wall St. Rank hold RPRX as of Q3 2025.

  • M&G plc reported no remaining Royalty Pharma position as of Q3 2025 after selling out during the quarter.
  • M&G plc sold 17,200 Royalty Pharma shares in Q3 2025, an estimated $619K.
  • M&G plc first reported a position in Royalty Pharma in Q2 2024 and held it in 5 quarters.
  • M&G plc's Royalty Pharma position peaked at $619K in Q2 2025.
  • 487 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2025.

Based on M&G plc's 13F filing for Q3 2025, filed 7 Nov 2025.